ASTERIX: Low Dose ASA and Nexium
Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00251966
Collaborator
(none)
960
93
16
10.3
0.6
Study Details
Study Description
Brief Summary
The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily for 26 Weeks.
Study Start Date
:
May 1, 2004
Actual Study Completion Date
:
Sep 1, 2005
Outcome Measures
Primary Outcome Measures
- The primary variable is presence of gastric and/or duodenal ulcers at endoscopy over a 26-week period in patients taking low-dose ASA. []
Secondary Outcome Measures
- LA classification for the oesophagus at endoscopy. Upper GI symptoms assessed by the investigator at each study visit. []
Eligibility Criteria
Criteria
Ages Eligible for Study:
60 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
A clinical diagnosis of a condition (cardiovascular and/or cerebrovascular protection or other reasons) that requires daily intake of low-dose ASA, 75-325 mg, and is expected to continue for the duration of the study (daily is defined as at least 5 days per week).
-
Age >= 60 years.
-
No gastric and/or duodenal ulcer at the baseline endoscopy.
-
- pylori negative by serology test at screening.
Exclusion Criteria:
-
Upper GI symptoms
-
Erosive oesophagitis
-
Malignancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Research Site | Bondi Junction | New South Wales | Australia | |
2 | Research Site | Bracken Ridge | Queensland | Australia | |
3 | Research Site | Carina Heights | Queensland | Australia | |
4 | Research Site | Adelaide | South Australia | Australia | |
5 | Research Site | Ashford | South Australia | Australia | |
6 | Research Site | Wayville | South Australia | Australia | |
7 | Research Site | Woodville | South Australia | Australia | |
8 | Research Site | Ballarat | Victoria | Australia | |
9 | Research Site | Malvern | Victoria | Australia | |
10 | Research Site | Burgas | Bulgaria | ||
11 | Research Site | Pleven | Bulgaria | ||
12 | Research Site | Russe | Bulgaria | ||
13 | Research Site | Sofia | Bulgaria | ||
14 | Research Site | Varna | Bulgaria | ||
15 | Research Site | Edmonton | Alberta | Canada | |
16 | Research Site | Winnipeg | Manitoba | Canada | |
17 | Research Site | Bay Roberts | Newfoundland and Labrador | Canada | |
18 | Research Site | Carbonear | Newfoundland and Labrador | Canada | |
19 | Research Site | St. John's | Newfoundland and Labrador | Canada | |
20 | Research Site | Halifax | Nova Scotia | Canada | |
21 | Research Site | Hamilton | Ontario | Canada | |
22 | Research Site | London | Ontario | Canada | |
23 | Research Site | North York | Ontario | Canada | |
24 | Research Site | Oakville | Ontario | Canada | |
25 | Research Site | Sudbury | Ontario | Canada | |
26 | Research Site | Thornhill | Ontario | Canada | |
27 | Research Site | Toronto | Ontario | Canada | |
28 | Research Site | Parkdale | Prince Edward Island | Canada | |
29 | Research Site | Courcelette | Quebec | Canada | |
30 | Research Site | Quebec | Canada | ||
31 | Research Site | Stuttgart | Baden-Württemberg | Germany | |
32 | Research Site | München | Bayern | Germany | |
33 | Research Site | Cottbus | Brandenburg | Germany | |
34 | Research Site | Frankfurt | Hessen | Germany | |
35 | Research Site | Rostock | Mecklenburg-Vorpommern | Germany | |
36 | Research Site | Hannover | Niedersachsen | Germany | |
37 | Research Site | Düsseldorf | Nordrhein-Westfalen | Germany | |
38 | Research Site | Münster | Nordrhein-Westfalen | Germany | |
39 | Research Site | Mainz | Rheinland-Pfalz | Germany | |
40 | Research Site | Halle | Sachsen-Anhalt | Germany | |
41 | Research Site | Hamburg | Germany | ||
42 | Research Site | Herne | Germany | ||
43 | Research Site | Köln | Germany | ||
44 | Research Site | Künzing | Germany | ||
45 | Research Site | Lienen | Germany | ||
46 | Research Site | Ludwigshafen | Germany | ||
47 | Research Site | Lüdenscheid | Germany | ||
48 | Research Site | Münster | Germany | ||
49 | Research Site | Oelde | Germany | ||
50 | Research Site | Paderborn | Germany | ||
51 | Research Site | Potsdam | Germany | ||
52 | Research Site | Ribnitz-Damgarten | Germany | ||
53 | Research Site | Rostock | Germany | ||
54 | Research Site | Siegen | Germany | ||
55 | Research Site | Wangen | Germany | ||
56 | Research Site | Wiesbaden | Germany | ||
57 | Research Site | Wolfenbüttel | Germany | ||
58 | Research Site | Wolmirstedt | Germany | ||
59 | Research Site | Zeven | Germany | ||
60 | Research Site | Athens | Greece | ||
61 | Research Site | Ioannina | Greece | ||
62 | Research Site | Piraeus | Greece | ||
63 | Research Site | Thessaloniki | Greece | ||
64 | Research Site | Hong Kong | Hong Kong | ||
65 | Research Site | Budapest | Hungary | ||
66 | Research Site | Debrecen | Hungary | ||
67 | Research Site | Eger | Hungary | ||
68 | Research Site | Gyula | Hungary | ||
69 | Research Site | Gy¿r | Hungary | ||
70 | Research Site | Kecskemét | Hungary | ||
71 | Research Site | Miskolc | Hungary | ||
72 | Research Site | Vác | Hungary | ||
73 | Research Site | Bologna | BO | Italy | |
74 | Research Site | Genova | GE | Italy | |
75 | Research Site | Parma | PR | Italy | |
76 | Research Site | Napoli | Italy | ||
77 | Research Site | Roma | Italy | ||
78 | Research Site | Cape Town | South Africa | ||
79 | Research Site | Johannesurg | South Africa | ||
80 | Research Site | Lyttelton Manor | South Africa | ||
81 | Research Site | Parktown | South Africa | ||
82 | Research Site | Tygerberg | South Africa | ||
83 | Research Site | Santiago de Compostela | A Coruña | Spain | |
84 | Research Site | Santiago | A Coruña | Spain | |
85 | Research Site | San Sebastián | Guipuzcoa | Spain | |
86 | Research Site | Granada | Spain | ||
87 | Research Site | Madrid | Spain | ||
88 | Research Site | Murcia | Spain | ||
89 | Research Site | Sevilla | Spain | ||
90 | Research Site | Irvine | Ayrshire | United Kingdom | |
91 | Research Site | Glasgow | Scotland | United Kingdom | |
92 | Research Site | Cardiff | South Wales | United Kingdom | |
93 | Research Site | Edinburgh | United Kingdom |
Sponsors and Collaborators
- AstraZeneca
Investigators
- Study Director: AstraZeneca Nexium Medical Science Director, MD, AstraZeneca
- Principal Investigator: Neville Yeomans, MD, Perth Medical School
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00251966
Other Study ID Numbers:
- D9617C00011
First Posted:
Nov 11, 2005
Last Update Posted:
Mar 12, 2009
Last Verified:
Mar 1, 2009
Keywords provided by ,
,
Additional relevant MeSH terms: